Contraception and birth control Archive

Men without evidence of low testosterone levels (hypogonadism) who use testosterone appear to face a higher risk of serious cardiovascular problems and death from all causes than men who use testosterone replacement therapy for documented hypogonadism, according to a 2026 study.

The FDA is considering labeling changes for testosterone replacement therapy (TRT) products. While the proposed changes would make TRT much more accessible, the FDA is still advising that use of TRT should be avoided in men with metastatic prostate cancer.

A new prostate cancer diagnosis can trigger fears about future cancers. Explore how age, genes, treatment, and lifestyle may affect your risk.

Doctors increasingly view erectile dysfunction as a potential early warning sign rather than just a sexual health issue. Research shows persistent erectile dysfunction is often tied to cardiovascular disease, and the two conditions share an array of risk factors.

Many women aren’t aware menopause can fuel oral health symptoms such as tooth decay, gum disease, and bone loss in the jaw. Reduced estrogen diminishes saliva production, which protects teeth and gums by neutralizing acids and bacteria. A variety of tools and techniques can help menopausal women preserve oral health.

Women on birth control who develop shingles may worry Valtrex could reduce protection. Find out if this antiviral impacts contraceptives.

When medications and lifestyle changes no longer control symptoms of an enlarged prostate, a range of surgical and minimally invasive procedures can restore urine flow. Each option offers different trade-offs in side effects, recovery, and duration of relief.

A 77-year-old man with a brother who died of prostate cancer weighs the pros and cons of PSA screening with age, health, and risk in mind.

Find out how estrogen-containing birth control can affect thyroid hormone replacement, and why your levothyroxine dose may need closer monitoring.

Men with low-risk prostate cancer continue to choose active surveillance as their course of action, meaning they monitor their cancer and don’t seek treatment unless it becomes worse. While this wait-and-see approach may appear passive in nature, it’s an opportunity for men to take charge of their health and make lifestyle changes that could improve their cancer outcome and offer protection against other health risks, like heart disease.